Insights
Featured Carousel
- Insights – June 2026
- AI-Enabled Vulnerability Discovery: What Next-Gen Tools Mean for the Management of Cybersecurity Risk
- Beyond Divestitures: The Global Shift Toward More Flexible Merger Remedies
- Federal Tax Credits Play a Key Role in Wind and Solar ‘Mega Projects’ as the Market Also Engages With Other Technologies
Topics Panel Section
Managing the Unique Risks of Buying a Founder-Led Brand: A Guide to Deal Terms
An array of deal structures has evolved to address the special risks of acquiring a business whose success is closely tied to its founder. Those include earn-outs, equity rollovers and hybrid investment-plus-commercial-partnership arrangements, all designed to align the buyer’s and the founder’s interests.
Managing the Unique Risks of Buying a Founder-Led Brand: A Guide to Deal Terms
CLARITY Act: Potential US Tax Implications for Digital Asset Market Participants
The proposed CLARITY Act would allocate regulatory jurisdiction over digital assets between the CFTC and SEC, giving the CFTC exclusive jurisdiction over spot markets in “digital commodities.” That could have implications for their treatment under the Internal Revenue Code.
CLARITY Act: Potential US Tax Implications for Digital Asset Market Participants
An array of deal structures has evolved to address the special risks of acquiring a business whose success is closely tied to its founder. Those include earn-outs, equity rollovers and hybrid investment-plus-commercial-partnership arrangements, all designed to align the buyer’s and the founder’s interests.
Managing the Unique Risks of Buying a Founder-Led Brand: A Guide to Deal Terms
The proposed CLARITY Act would allocate regulatory jurisdiction over digital assets between the CFTC and SEC, giving the CFTC exclusive jurisdiction over spot markets in “digital commodities.” That could have implications for their treatment under the Internal Revenue Code.
CLARITY Act: Potential US Tax Implications for Digital Asset Market Participants
Carve-outs and divestitures in China and Southeast Asia pose unique challenges because tax, foreign ownership, data transfer and other laws in various Asian jurisdictions can affect the deal structure and rule out some potential buyers.
Carve-Outs and Divestitures: Structuring and Execution Considerations for China and Southeast Asia
The departure of the drug regulator’s chief and much of its senior leadership leaves the fate of many of the novel initiatives undertaken over the past year unclear, making it harder for FDA-regulated companies to plan.
FDA Leadership Upheaval: What Comes Next?
Carve-Outs and Divestitures: Structuring and Execution Considerations for China and Southeast Asia
Carve-outs and divestitures in China and Southeast Asia pose unique challenges because tax, foreign ownership, data transfer and other laws in various Asian jurisdictions can affect the deal structure and rule out some potential buyers.
Carve-Outs and Divestitures: Structuring and Execution Considerations for China and Southeast Asia
FDA Leadership Upheaval: What Comes Next?
The departure of the drug regulator’s chief and much of its senior leadership leaves the fate of many of the novel initiatives undertaken over the past year unclear, making it harder for FDA-regulated companies to plan.
FDA Leadership Upheaval: What Comes Next?
Latest From Skadden
-
Beyond Divestitures: The Global Shift Toward More Flexible Merger RemediesJune 23, 2026
-
Carve-Outs and Divestitures: Structuring and Execution Considerations for China and Southeast AsiaJune 23, 2026
-
Managing the Unique Risks of Buying a Founder-Led Brand: A Guide to Deal TermsJune 23, 2026